— Know what they know.
Not Investment Advice

NKTX NASDAQ

Nkarta, Inc.
1W: +7.8% 1M: -1.9% 3M: +30.0% YTD: +50.8% 1Y: +78.2% 3Y: -19.2% 5Y: -90.6%
$3.03
+0.00 (+0.00%)
 
Weekly Expected Move ±10.0%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 48 · $216.8M mcap · 54M float · 1.52% daily turnover · Short 36% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$9M +0.0% ▲
Operating Income
-$121M +5.5% ▲
Net Income
-$104M +4.3% ▲
EPS (Diluted)
$-1.41 +11.9% ▲
EBITDA
-$112M +5.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$6M$0$9M
Gross Profit$0$0-$6M$0-$9M
Gross Margin
R&D Expenses$63M$91M$91M$97M$90M
SG&A Expenses$23M$28M$35M$31M$32M
Operating Expenses$86M$119M$126M$128M$112M
Operating Income-$86M-$119M-$132M-$128M-$121M
Operating Margin
Interest Expense$0$6M$0$0$0
Income Before Tax-$86M-$114M-$118M-$109M-$104M
Tax Expense$0$0$0$0$0
Net Income-$86M-$114M-$118M-$109M-$104M
Net Margin
EPS (Diluted)$-2.62$-2.61$-2.40$-1.60$-1.41
EBITDA-$85M-$116M-$120M-$119M-$112M
Shares Outstanding33M44M49M68M74M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms